Richard Williams
Directeur Technique/Scientifique/R&D chez KINNATE BIOPHARMA INC.
Profil
Richard Williams is currently the Chief Medical Officer at Kinnate Biopharma, Inc. He previously worked as a Clinical Research Medical Director at Amgen, Inc. from 2010 to 2012, as a Senior Medical Director at Puma Biotechnology, Inc. from 2012 to 2015, as the Head-Early Development Oncology Group at Amgen, Inc. from 2016 to 2017, as the Group Director-Medical at GRAIL LLC in 2017, and as the Chief Medical Officer & Head-Oncology Programs at Wuxi NextCode Genomics USA, Inc. from 2018 to 2020.
Dr. Williams holds a doctorate degree from The University of Queensland.
Postes actifs de Richard Williams
| Sociétés | Poste | Début |
|---|---|---|
| KINNATE BIOPHARMA INC. | Directeur Technique/Scientifique/R&D | 01/06/2020 |
Anciens postes connus de Richard Williams
| Sociétés | Poste | Fin |
|---|---|---|
Wuxi NextCode Genomics USA, Inc.
 Wuxi NextCode Genomics USA, Inc. Data Processing ServicesTechnology Services Wuxi NextCode Genomics USA, Inc. provides genomic data. It's solutions include custom patient cohorts, sequencing, analysis, AI services, sequence miner, and clinical sequence analyzer. The company was founded by Jeffrey Gulcher and Hannes Smarason and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/06/2020 |
GRAIL LLC
 GRAIL LLC Medical SpecialtiesHealth Technology GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Directeur Technique/Scientifique/R&D | 01/02/2018 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2017 |
| PUMA BIOTECHNOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/09/2015 |
| AMGEN INC. | Corporate Officer/Principal | 01/11/2012 |
Formation de Richard Williams
| The University of Queensland | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
 | Health Technology |
| AMGEN INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
Wuxi NextCode Genomics USA, Inc.
Wuxi NextCode Genomics USA, Inc. Data Processing ServicesTechnology Services Wuxi NextCode Genomics USA, Inc. provides genomic data. It's solutions include custom patient cohorts, sequencing, analysis, AI services, sequence miner, and clinical sequence analyzer. The company was founded by Jeffrey Gulcher and Hannes Smarason and is headquartered in Cambridge, MA. | Technology Services |
